Home / Fact sheets / Population fact sheet

Country fact sheet: Hungary

Population

- Total population: 9 814 023
- Female population: 5 147 451
- Male population: 4 666 572
The World Bank (2016)

Health Expenditure

- Total per capita (US$): 893.7
- Out-of-pocket (% of total expenditure on health): 29.0
World Health Organization (2015)

Human Development Index

- HDI: 0.836
- Category: Very high
UNDP Human Development Report (2015)

Geography

Life Expectancy at Birth

- Total population (years): 75.6
- Female population (years): 79.0
- Male population (years): 72.3
The World Bank (2016)

Cancer Burden

- Overall cancer incidence (rate per 100 000 persons per year): 368.1
- Overall cancer mortality (rate per 100 000 persons per year): 155.8
- Most common cancer site by incidence for females (rate per 100 000 persons per year): Breast (85.5)
- Most common cancer site by mortality for females (rate per 100 000 persons per year): Lung (30.9)
- Most common cancer site by incidence for males (rate per 100 000 persons per year):  (77.4)
- Most common cancer site by mortality for males (rate per 100 000 persons per year): Lung (62.9)
- GLOBOCAN 2018 population fact sheet
GLOBOCAN (2018)

BREAST CANCER SCREENING PROGRAMME

Last updated year for qualitative data: 2016
Source of data: Report (EU Report 2017)
Last updated year for quantitative data: 2013
Source of data: Report (EU Report 2017)

Screening protocol

Year published/updated:
Screening test used: 1
Target age (min-max) and screening interval [months] for each test: Mammography
(45-64 years / [24 months] )

Programme status and organization

Dedicated person/team to coordinate the programme:
Budget line for screening programme:
Documented cancer screening policy:
Nature of documentation of the policy: Law
Program introduction was preceded by a pilot:
Year program was initiated: 2001
Screening tests provided free of charge:
Diagnostic tests provided free of charge:
Treatment services provided free of charge:

Information system/Data collection

Data type collected by the programme: Individual and aggregate
The information system collects data outside the program (opportunistic screening/private sector):
Cancer screening registries covering the entire country/region:
Cancer screening data is linked with Population-based cancer registry:

Invitation to screening and further assessment

Method of identification of eligible individuals: From population data
Source of population data: Population register
Annual target for screening coverage:
Invitations to eligible population: Excluding those covered by opportunistic screening
Method of invitation: letter
Screen positive individuals actively invited for further assessment:
Individuals with a precancer or cancer diagnosis actively contacted:
Program collects data on the treatment of precancer/cancers:

Programme monitoring and quality assurance (QA)

Documented standard operating procedure/policy for QA:
Responsible person/team for QA:
Documented performance indicators and their reference standards to assess the programme:
Evaluation reports are prepared and published:

Cancer Screening programme status

Nature of cancer screening programme: Population-based and non population-based
Current status of implementation (applicable only for population-based programmes): Roll-out completed
Cancer screening programme population based for selected populations:

Performance indicators

Target age and regional limitation if applicable:
Invitation coverage (%):
Examination coverage (%):
Participation rate (%):
Completeness of data related to screening results (%):
Completeness of data related to further assessment results (%):
Further assessment rate (%):
Further assessment participation rate (%):
Detection rate of CIS and invasive (x 1000):
Detection rate of invasive cancer (x 1000):
Positive predictive value of further assessment to detect CIS and invasive (%):
Proportion of total carcinomas which are CIS (%):
Benign surgical biopsy rate (x 1000):
More quantitative data (2013)



CERVICAL CANCER SCREENING PROGRAMME

Last updated year for qualitative data: 2016
Source of data: Report (EU Report 2017)
Last updated year for quantitative data: 2013
Source of data: Report (EU Report 2017)

Screening protocol

Year published/updated:
Screening test used: 1
Target age (min-max) and screening interval [months] for each test: Cytology
(25-65 years / [36 months] )
Triaging test used: None
"screen and treat" included in the protocol:

Programme status and organization

Dedicated person/team to coordinate the programme:
Budget line for screening programme:
Documented cancer screening policy:
Nature of documentation of the policy: Law
Program introduction was preceded by a pilot:
Year program was initiated: 2003
Screening tests provided free of charge:
Diagnostic tests provided free of charge:
Treatment services provided free of charge:

Information system/Data collection

Data type collected by the programme: Individual and aggregate
The information system collects data outside the program (opportunistic screening/private sector):
Cancer screening registries covering the entire country/region:
Cancer screening data is linked with population-based cancer registry:

Invitation to screening and further assessment

Method of identification of eligible individuals: From population data
Source of population data: Population register
Annual target for screening coverage:
Invitations to eligible population: For the entire target population
Screening kit included with the invitation:
Method of invitation: letter
Screen positive individuals actively invited for further assessment:
Individuals with a precancer or cancer diagnosis actively contacted:
Program collects data on the treatment of precancer/cancers:

Programme monitoring and quality assurance (QA)

Documented standard operating procedure/policy for QA:
Responsible person/team for QA:
Documented performance indicators and their reference standards to assess the programme:
Evaluation reports are prepared and published:

Cancer Screening programme status

Nature of cancer screening programme: Population-based
Current status of implementation: Roll-out on going
Cancer screening programme population based for selected populations/regions:

Performance indicators

Target age and regional limitation if applicable: 30-59 years
Invitation coverage (%): 15.2
Examination coverage (invitation cohort) (%): 4.6
Examination coverage (tests in the index-year) (%): 52.4
Participation rate (%): 30.1
Completeness of data related to screening test results (%): 100
Completeness of data related to further assessment results (%): 0
Colposcopy referral rate (%): 118.3
Colposcopy participation rate (%): 100.0 (all ages)
Detection rate of CIN2+ (x 1000):
Detection rate of CIN3+ (x 1000):
Positive Predictive Value of abnormal screening test to detect CIN2+ (x 1000):
Positive Predictive Value of CIN3+ (x 1000):
More quantitative data (2013)



COLORECTAL CANCER SCREENING PROGRAMME

Last updated year for qualitative data: 2013
Source of data: Report (EU Report 2017)
Last updated year for quantitative data: 2013
Source of data: No source

Screening protocol

Year published/updated:
Screening test used: 1
Target age (min-max) and screening interval [months] for each test: FIT: (50-70 years / [24 months] )

Programme status and organization

Dedicated person/team to coordinate the programme:
Budget line for screening programme:
Documented cancer screening policy:
Nature of documentation of the policy: Law
Program introduction was preceded by a pilot:
Year program was initiated: 2007
Screening tests provided free of charge:
Diagnostic tests provided free of charge:
Treatment services provided free of charge:

Information system/Data collection

Data type collected by the programme: Individual and aggregate
The information system collects data outside the program (opportunistic screening/private sector):
Cancer screening registries covering the entire country/region:
Cancer screening data is linked with population-based cancer registry:

Invitation to screening and further assessment

Method of identification of eligible individuals: From population data
Source of population data: List from insurance company
Annual target for screening coverage:
Invitations to eligible population: Excluding those covered by opportunistic screening
Method of invitation: letter
Screen positive individuals actively invited for further assessment:
Individuals with a precancer or cancer diagnosis actively contacted:
Program collects data on the treatment of precancer/cancers:

Programme monitoring and quality assurance (QA)

Documented standard operating procedure/policy for QA:
Responsible person/team for QA:
Documented performance indicators and their reference standards to assess the programme:
Evaluation reports are prepared and published:

Cancer Screening programme status

Nature of cancer screening programme: Population-based
Current status of implementation (applicable only for population-based programmes): Pilot
Cancer screening programme population based for selected populations:

Performance indicators

FIT gFOBT sigmoidoscopy Colonoscopy
Target age and regional limitation if applicable: 50-74
Invitation coverage (%): 1.5
Examination coverage (%):
Participation rate (%):
Completeness of data related to screening results (%): 94.5
Completeness of data related to information about attendance to colonoscopy assessment (%): 100.1
Completeness of data related to histology result (%): 86.4
Screen positivity (indication for follow-up colonoscopy) rate (%) : 9.1
Follow-up colonoscopy participation rate (%): 65.3
Completion rate follow-up colonoscopy (%): 100.2
Detection rate of adenomas (x 1000): 30.3
Detection rate of advanced adenomas (x 1000):
Detection rate of colorectal cancers (x 1000): 3.3
Positive Predictive Value of further assessment to detect adenomas (%): 51.1
Positive Predictive Value of further assessment to detect advanced adenomas (%):
Positive Predictive Value of further assessment to detect colorectal cancers (%): 5.3
More quantitative data for FIT (Male - 2013)
More quantitative data for FIT (Women - 2013)